多个目标,一个目标:通过多药理学加剧延长生命效应
K Avchaciov1, K J Clay2, K Denisov1,2
1Gero PTE, 60 Paya Lebar Road # 05-40B, Paya Lebar Square, 409051, Singapore.
bioRxiv : the preprint server for biology
|July 9, 2024
概括
研究人员开发了一种使用图形神经网络的新方法来识别强大的老年保护剂. 这些化合物向多个受体,显著延长了C. elegans的寿命,证明了对抗衰老药物发现的新方法.
科学领域:
- 老年病学和药理学.
- 计算机化药物发现.
- 分子生物学分子生物学
背景情况:
- 最有效的延长寿命的化合物或老年保护剂通常与多个生物氨基酶受体相互作用.
- 了解多药理学是开发高效的抗衰老干预措施的关键.
研究的目的:
- 测试假设,针对多个生物氨基受体的多药物化合物是优越的老年保护剂.
- 利用图形神经网络开发一种用于识别此类化合物的预测模型.
- 通过实验验证预测化合物在延长寿命方面的有效性.
主要方法:
- 利用图形神经网络 (GNN) 进行多药物化合物的 in silico 预测.
- 根据GNN预测选择的化合物,针对多个生物氨基酶受体.
- 评估了在模型生物*C. elegans*中选择的化合物的寿命延长效应.
- 与DrugAge数据库中现有的数据比较已识别的基因保护剂的疗效.
主要成果:
- 在GNN选择的化合物中,超过70%的化合物在C. elegans*中显著延长了寿命.
- 与DrugAge数据库相比,观察到的寿命延长效应大小在前5%中.
- 这证实了GNN在识别强大的老年保护剂方面的预测能力.
结论:
- 合理设计多药物化合物是开发高效老年保护剂的可行策略.
- 基于图形神经网络的预测为发现新型抗衰老化合物提供了强大的方法.
- 这项研究突出了针对多个生物氨基受体的潜力,以显著延长寿命.
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
119
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
119
Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Nonlinear Pharmacokinetics: Overview
340
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
340
Nonlinear Pharmacokinetics: Causes of Nonlinearity
171
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
171


